INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 31 December 2015
Net Assets |
£239m |
Net Assets per share |
602p |
Share price |
541p |
Total value of unquoted investments |
£21m |
Total number of portfolio companies |
92 |
Top Ten Holdings
Company Name |
% NAV |
Celgene |
8.0 |
Amgen |
8.0 |
Regeneron |
7.6 |
Gilead |
7.1 |
Alexion |
5.2 |
Biogen |
4.8 |
Biomarin |
3.5 |
Vertex |
3.4 |
Ophthotech |
3.3 |
Incyte |
2.8 |
|
----------- |
Total |
53.7 |
Portfolio Profitability |
% NAV |
Profitable |
54 |
Turning Profitable 2016 |
9 |
Unprofitable |
37 |
|
----------- |
Total |
100 |
Geographical Allocation |
% NAV |
US & Canada |
83 |
Europe & UK |
17 |
|
----------- |
Total |
100 |
Quoted/Unquoted Allocation |
% NAV |
Quoted |
92 |
Unquoted |
8 |
|
----------- |
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
25 JANUARY 2016